---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-029124"
form_type: "8-K"
ticker: "TECX"
cik: "0001681087"
company_name: "Tectonic Therapeutic, Inc."
filed_at: "2023-06-09T23:59:59+00:00"
generated_at: "2026-06-14T03:59:53.001760+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# AVROBIO approves $250K in transaction bonuses for CEO and CTO tied to cystinosis program sale

## Summary
- Transaction bonuses of $150k for President/Interim CEO/CFO Erik Ostrowski and $100k for CTO Azadeh Golipour, payable in three installments after Asset Sale closing.
- Bonuses contingent on closing of previously announced sale of cystinosis gene therapy program; forfeiture if resignation/termination before payment.
- Stockholders elected directors Ian Clark and Annalisa Jenkins as Class II directors for term until 2026 annual meeting.
- Ratification of Ernst & Young as independent auditor for FY2023 with over 34 million votes for.

## SEC filing metadata
- accession: 0001140361-23-029124
- form_type: 8-K
- ticker: TECX
- cik: 0001681087
- company_name: Tectonic Therapeutic, Inc.
- filed_at: 2023-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681087/000114036123029124/0001140361-23-029124-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681087/000114036123029124/brhc20054224_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-029124
- JSON: https://secwatch.observer/filing/0001140361-23-029124.json
- Plain text: https://secwatch.observer/filing/0001140361-23-029124.txt

## Key facts
- Shareholder Votes
  Tectonic Therapeutic, Inc. shareholders approved Election of two Class II directors at the 2023-06-06 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: The Company’s stockholders elected the two director nominees listed below to serve as Class II directors until the Company’s 2026 annual meeting of stockholders, with the votes cast as follows: Director Nominee Votes For Votes Withheld Broker Non-Votes Ian Clark 20,810,217 5,332,015 8,660,564 Annalisa Jenkins, M.B.B.S., F.R.C.P. 16,685,601 9,456,631 8,660,564
  evidence_url: https://www.sec.gov/Archives/edgar/data/1681087/000114036123029124/0001140361-23-029124-index.htm
- Shareholder Votes
  Tectonic Therapeutic, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-06 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, with the votes cast as follows: Votes For Votes Against Abstentions Broker Non-Votes 34,092,579 33,201 677,016 --
  evidence_url: https://www.sec.gov/Archives/edgar/data/1681087/000114036123029124/0001140361-23-029124-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.